eCOA Scientist interested in effective decision-making in healthcare & measurement of meaningful outcomes.
London
Joined April 2011
- Tweets622
- Following293
- Followers280
- Likes371
Pinned Tweet
Incredibly proud to see this very important article I led with @ConsortiumEcoa on ePRO Implementation & Migration Best Practices published @ISPORJournals, so it is available immediately for use by the clinical research community. valueinhealthjournal.com/art…
@ObvioHealth
Dr Flo Mowlem retweeted
#CPath is proud to welcome @ObvioHealth as the newest member of its Electronic Clinical Outcome Assessment Consortium.
Welcome aboard, #ObvioHealth!
Learn more about the #eCOA #Consortium here: lnkd.in/gHPvtgeB
Dr Flo Mowlem retweeted
@Windrushtriclub is hosting their annual Aquathlon in with a swim in the famous Brockwell Lido followed by the run leg in Brockwell Park. Entries are open for adults and children.
It's a great day out! Get signed up! britishtriathlon.org/events/…
An important paper for our industry is out:
Updated Recommendations on Evidence Needed to Support Measurement Comparability Among Modes of Data Collection for … pubmed.ncbi.nlm.nih.gov/3712…
Dr Flo Mowlem retweeted
#ISPORnews: New ISPOR Good Practices Report published in Value in Health. Global expert panel developed new guidance on measurement comparability between methods of patient data collection. #HEOR #ValueInHealth #PROs
ow.ly/NZwq50OjEUA
ALT Value in Health, May 2025 issue cover
Attend my webinar!
Leverage Novel Options in Oncology Clinical Trial Design to Reduce Burden For Patients and Sites xtalks.com/webinars/leverage… via @xtalks @medableinc
Building a Clinical Team in a Large Technology Company | Catalyst non-issue content catalyst.nejm.org/doi/full/1…
The message is clear: inclusion of decentralised elements doesn't change guiding principles of trial conduct: participant rights & safety should prevail & data robustness for reg decision-making shld be guaranteed. What the EU recommendation paper tells us lnkd.in/emXh-Y2F
Had a great week in Copenhagen, visiting wonderful colleagues and presenting @ArenaIntOCT on how we can optimise Patient-Focused Drug Development in Oncology through flexible clinical trial designs supported by tech, with optionality at the centre and upfront planning essential.
Look forward to attending @ArenaIntOCT next week in wonderful Copenhagen. I'll be discussing Patient Focused Drug Development in Oncology & opportunities to optimise clinical trial design to reduce participant & site burden - listen on Tues 25th or drop by the @medableinc booth
Dr Flo Mowlem retweeted
Hello! Could you maybe deliver those marmalade sandwiches to people who need them rather than leaving them outside a palace? Thanks.
“Female innovators must stay in the game and keep fighting” - htworld.co.uk/news/female-in…
How Can We Increase The Adoption Of Bring-Your-Own-Device (BYOD) For Capturing Patient-Reported Outcomes (PROs) In Clinical Trials? lifescienceleader.com/doc/ho…
Was delighted to contribute to this article with @yelenaizmailova for the eCOA Consortium @CPathInstitute
Progressing BYOD Adoption appliedclinicaltrialsonline.… via @appliedclinicaltrial online
#BYOD #ePRO #clinicaltrials
I'll be presenting @_DiMeSociety Journal Club on Thursday! Join if you can!
Regulatory Acceptance of Patient-Reported Outcome (PRO) Data from Bring-Your-Own-Device (BYOD) Solutions to Support Medical Product Labeling Claims dimesociety.org/journal/regu…
Looking forward to speaking about Adoption of BYOD @ArenaIntPharma OCT 14 June. lnkd.in/ewCZ4Ahy
Response to the pledge to contribute to a database of BYOD use in clinical trials for ePRO is encouraging lnkd.in/e-VZe7e2
#clinicaltrials #data #BYOD #epro #regulators
New @medableinc paper out, calling for more transparency around BYOD use.
Pledge your intention to contribute to a database of PRO endpoints collected via BYOD by completing the poll within the blog below.
Article: lnkd.in/ewCZ4Ahy
Blog: lnkd.in/eY9CxvtK